Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.

Tytuł:
Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.
Autorzy:
Oshio T; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan; Department of Dermatology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Kawashima R; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan; Kitasato University Graduate School of Medical Sciences, Sagamihara, Kanagawa, Japan.
Kawamura YI; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Hagiwara T; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Mizutani N; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Okada T; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Otsubo T; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Inagaki-Ohara K; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Matsukawa A; Department of Pathology & Experimental Medicine, Okayama University, Okayama, Okayama, Japan.
Haga T; Department of Life Science, Gakushuin University, Mejiro-ku, Tokyo, Japan.
Kakuta S; Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Iwakura Y; Division of Experimental Animal Immunology, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
Hosokawa S; Department of Applied Chemistry, Faculty of Advanced Science and Engineering, Waseda University, Shinjuku-ku, Tokyo, Japan.
Dohi T; Department of Gastroenterology, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
Źródło:
PloS one [PLoS One] 2014 Apr 08; Vol. 9 (4), pp. e94445. Date of Electronic Publication: 2014 Apr 08 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Cytokines/*biosynthesis
Macrophages, Peritoneal/*metabolism
Receptors, CCR8/*metabolism
Animals ; Chemokine CCL1/antagonists & inhibitors ; Chemotaxis/drug effects ; Chemotaxis/immunology ; Colitis/genetics ; Colitis/immunology ; Colitis/metabolism ; Disease Models, Animal ; Inflammation/genetics ; Inflammation/immunology ; Inflammation/metabolism ; Intracellular Space/metabolism ; Lipopolysaccharides/immunology ; Macrophages/drug effects ; Macrophages/immunology ; Macrophages/metabolism ; Macrophages, Peritoneal/drug effects ; Macrophages, Peritoneal/immunology ; Male ; Mice ; Mice, Knockout ; Protein Transport ; Receptors, CCR8/antagonists & inhibitors ; Receptors, CCR8/deficiency ; Receptors, CCR8/genetics ; Signal Transduction/drug effects ; Toll-Like Receptors/metabolism
References:
J Immunol. 1998 Nov 15;161(10):5111-5. (PMID: 9820476)
J Leukoc Biol. 2007 Jul;82(1):16-32. (PMID: 17456803)
Cancer Res. 2009 Oct 1;69(19):7884-92. (PMID: 19773434)
J Immunol. 1998 Jul 15;161(2):547-51. (PMID: 9670926)
Clin Vaccine Immunol. 2011 Dec;18(12):2050-9. (PMID: 21976223)
Nat Immunol. 2001 Apr;2(4):338-45. (PMID: 11276205)
J Immunol. 2000 Jun 15;164(12):6303-12. (PMID: 10843684)
J Immunoassay Immunochem. 2012;33(3):291-301. (PMID: 22738652)
FASEB J. 2006 Feb;20(2):302-4. (PMID: 16384913)
J Med Chem. 2007 Feb 8;50(3):566-84. (PMID: 17266208)
Immunol Res. 2012 Dec;54(1-3):111-20. (PMID: 22466932)
J Immunol. 2000 Apr 15;164(8):4048-54. (PMID: 10754297)
J Exp Med. 1997 Jul 7;186(1):165-70. (PMID: 9207005)
Biochem Biophys Res Commun. 2008 Mar 28;368(1):94-9. (PMID: 18222170)
Nat Immunol. 2011 Feb;12(2):167-77. (PMID: 21217759)
Int Immunol. 2005 Aug;17(8):1023-34. (PMID: 16000328)
J Immunol. 2010 Jun 15;184(12):6843-54. (PMID: 20483766)
Immunology. 1988 Aug;64(4):719-24. (PMID: 2844658)
J Immunol. 1993 Feb 1;150(3):1011-8. (PMID: 8423328)
Biochem Biophys Res Commun. 2011 Apr 22;407(4):764-71. (PMID: 21439940)
J Immunol. 2007 Nov 1;179(9):5760-7. (PMID: 17947648)
J Immunol. 2005 Apr 15;174(8):5082-91. (PMID: 15814739)
J Exp Med. 2001 Mar 5;193(5):573-84. (PMID: 11238588)
Cell Mol Immunol. 2004 Apr;1(2):95-104. (PMID: 16212895)
Nat Immunol. 2011 Feb;12(2):111-2. (PMID: 21245898)
J Immunol. 1998 Feb 15;160(4):1975-81. (PMID: 9469461)
J Immunol. 2007 Apr 15;178(8):5296-304. (PMID: 17404314)
J Exp Med. 2001 Sep 17;194(6):847-53. (PMID: 11560999)
Thorax. 2013 Jun;68(6):506-12. (PMID: 23457038)
J Immunol. 2006 May 15;176(10):6211-8. (PMID: 16670331)
J Biol Chem. 1989 Dec 5;264(34):20240-7. (PMID: 2511200)
J Immunol. 1995 May 15;154(10):5376-83. (PMID: 7730638)
Science. 1986 Nov 7;234(4777):743-6. (PMID: 3095921)
Substance Nomenclature:
0 (Chemokine CCL1)
0 (Cytokines)
0 (Lipopolysaccharides)
0 (Receptors, CCR8)
0 (Toll-Like Receptors)
Entry Date(s):
Date Created: 20140410 Date Completed: 20141203 Latest Revision: 20211021
Update Code:
20240104
PubMed Central ID:
PMC3979852
DOI:
10.1371/journal.pone.0094445
PMID:
24714157
Czasopismo naukowe
Chemokine (C-C motif) receptor 8 (CCR8), the chemokine receptor for chemokine (C-C motif) ligand 1 (CCL1), is expressed in T-helper type-2 lymphocytes and peritoneal macrophages (PMφ) and is involved in various pathological conditions, including peritoneal adhesions. However, the role of CCR8 in inflammatory responses is not fully elucidated. To investigate the function of CCR8 in macrophages, we compared cytokine secretion from mouse PMφ or bone marrow-derived macrophages (BMMφ) stimulated with various Toll-like receptor (TLR) ligands in CCR8 deficient (CCR8-/-) and wild-type (WT) mice. We found that CCR8-/- PMφ demonstrated attenuated secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 when stimulated with lipopolysaccharide (LPS). In particular, LPS-induced IL-10 production absolutely required CCR8. CCR8-dependent cytokine secretion was characteristic of PMφ but not BMMφ. To further investigate this result, we selected the small molecule compound R243 from a library of compounds with CCR8-antagonistic effects on CCL1-induced Ca2+ flux and CCL1-driven PMφ aggregation. Similar to CCR8-/- PMφ, R243 attenuated secretion of TNF-α, IL-6, and most strikingly IL-10 from WT PMφ, but not BMMφ. CCR8-/- PMφ and R243-treated WT PMφ both showed suppressed c-jun N-terminal kinase activity and nuclear factor-κB signaling after LPS treatment when compared with WT PMφ. A c-Jun signaling pathway inhibitor also produced an inhibitory effect on LPS-induced cytokine secretion that was similar to that of CCR8 deficiency or R243 treatment. As seen in CCR8-/- mice, administration of R243 attenuated peritoneal adhesions in vivo. R243 also prevented hapten-induced colitis. These results are indicative of cross talk between signaling pathways downstream of CCR8 and TLR-4 that induces cytokine production by PMφ. Through use of CCR8-/- mice and the new CCR8 inhibitor, R243, we identified a novel macrophage innate immune response pathway that involves a chemokine receptor.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies